U.S. FDA Panel Addresses Oximeter's Effectivity on Darker Skin Tones as 'Critical' Amidst COVID-19
The U.S. FDA will hold a meeting to discuss the underlying flaw of the oximeter after Health professionals and researchers called out the agency.
Source: techtimes.com